Different affinities of tamoxifen binding sites in the estrogen receptor of breast cancer

Citation
L. Calzada et al., Different affinities of tamoxifen binding sites in the estrogen receptor of breast cancer, MED SCI RES, 26(12), 1998, pp. 829-830
Citations number
14
Categorie Soggetti
Medical Research General Topics
Journal title
MEDICAL SCIENCE RESEARCH
ISSN journal
02698951 → ACNP
Volume
26
Issue
12
Year of publication
1998
Pages
829 - 830
Database
ISI
SICI code
0269-8951(199812)26:12<829:DAOTBS>2.0.ZU;2-E
Abstract
We have subjected cytosol, isolated from hormone-dependent tumour tissue fr om women with breast cancer, to saturation analysis over a wide range of [H -3-] estradiol and tamoxifen concentrations. This analysis revealed differe nt binding sites to tamoxifen on the estradiol receptor. The union specific values analysed by the Scatchard method were in the range 175-350 fmol/mg protein. When cytosol was pre-treated with 0.5, 1.0 and 5 mu M tamoxifen th ere was 50%, 70% and 94% inhibition of the estradiol-receptor complex respe ctively. The inhibition was significantly different when individual cytosol s were incubated with tamoxifen at 5 CIM. At levels of estradiol receptor < 50 fmol/mg protein, the inhibition by tamoxifen was 50-60%, while a levels > 50 fmol/mg protein it was 85-95%. The different affinities of these bind ing sites to tamoxifen may thus provide additional information about the se nsitivity of breast cancer. Med Sci Res 26:829-830. (C) 1998 Lippincott Wil liams & Wilkins.